Imagine Healthcare PLLC Press Releases

• Published on January 31, 2025 - 22:35 GMT

  Imagine Healthcare Announces Expanded Access to Spravato - Now Available Without the Need for an Oral Antidepressant

  Spravato® (esketamine) has been approved for use as a standalone treatment for depression, without the requirement of an accompanying antidepressant. CHICAGO, IL, UNITED STATES, January 31, 2025 /⁨EINPresswire.com⁩/ -- Imagine Healthcare, a leading mental …

  Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
• Published on March 20, 2024 - 20:11 GMT

  

  Imagine Healthcare Revolutionizes Mental Healthcare in Chicago with Spravato

  Imagine Healthcare is offering a no waitlist for treatment. CHICAGO, ILLINOIS, UNITED STATES, March 20, 2024 /⁨EINPresswire.com⁩/ -- Imagine Healthcare, a leading healthcare provider in Chicago, is proud to announce the availability of Spravato treatment …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...